Literature DB >> 7749409

Concentration of mutations causing Schmid metaphyseal chondrodysplasia in the C-terminal noncollagenous domain of type X collagen.

I McIntosh1, M H Abbott, C A Francomano.   

Abstract

Schmid metaphyseal chondrodysplasia (SMCD) has previously been shown to be the result of mutations in the type X collagen gene, COL10A1. A further three mutations have been identified, including two nonsense mutations (Y268X, W651X) and a frameshift mutation (1856delCC). Each of the 10 SMCD mutations identified to date is within the C-terminal noncollagenous domain of type X collagen and three of five deletions initiated around the same nucleotide. This domain is believed to be involved in the initiation of collagen trimerization. The concentration of mutations within this domain is consistent with the hypothesis that the phenotype is the result of a reduction in the level of mature type X collagen due to the mutant polypeptide's inability to participate in trimer formation, although a dominant-negative mechanism cannot be discounted, on the basis of current evidence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749409     DOI: 10.1002/humu.1380050204

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

1.  Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.

Authors:  A De Paepe; L Nuytinck; I Hausser; I Anton-Lamprecht; J M Naeyaert
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Mutations within the gene encoding the alpha 1 (X) chain of type X collagen (COL10A1) cause metaphyseal chondrodysplasia type Schmid but not several other forms of metaphyseal chondrodysplasia.

Authors:  G A Wallis; B Rash; B Sykes; J Bonaventure; P Maroteaux; B Zabel; R Wynne-Davies; M E Grant; R P Boot-Handford
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

Review 3.  Etiology of osteoarthritis: genetics and synovial joint development.

Authors:  Linda J Sandell
Journal:  Nat Rev Rheumatol       Date:  2012-01-10       Impact factor: 20.543

4.  Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development.

Authors:  Ming Ding; Yaojuan Lu; Sam Abbassi; Feifei Li; Xin Li; Yu Song; Valérie Geoffroy; Hee-Jeong Im; Qiping Zheng
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

5.  Deletions in the COL10A1 gene are not associated with skeletal changes in dogs.

Authors:  Amy E Young; Jeanne R Ryun; Danika L Bannasch
Journal:  Mamm Genome       Date:  2006-07-14       Impact factor: 2.957

6.  Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function.

Authors:  K M Kwan; M K Pang; S Zhou; S K Cowan; R Y Kong; T Pfordte; B R Olsen; D O Sillence; P P Tam; K S Cheah
Journal:  J Cell Biol       Date:  1997-01-27       Impact factor: 10.539

7.  Growth plate compressions and altered hematopoiesis in collagen X null mice.

Authors:  C J Gress; O Jacenko
Journal:  J Cell Biol       Date:  2000-05-15       Impact factor: 10.539

8.  Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation.

Authors:  J Gu; Y Lu; F Li; L Qiao; Q Wang; N Li; J A Borgia; Y Deng; G Lei; Q Zheng
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

9.  Identification of two novel COL10A1 heterozygous mutations in two Chinese pedigrees with Schmid-type metaphyseal chondrodysplasia.

Authors:  Lingchi Kong; Li Shi; Wenbo Wang; Rongtai Zuo; Mengwei Wang; Qinglin Kang
Journal:  BMC Med Genet       Date:  2019-12-19       Impact factor: 2.103

10.  Identification of a novel COL10A1: c.1952 G>T variant in a family with Schmid metaphyseal chondrodysplasia and development of a noninvasive prenatal testing method.

Authors:  Yanchou Ye; Weihao Li; Guan Wang; Longsheng Zhan; Junwei Lin; Tian Li; Jun Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-08-23       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.